• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Redwood Pharma

Less than 1K followers
All
Press releases
3rd party
ShowingAll content types

Regulatory press release28.07.2024, 14.30

Redwood Pharma files for bankruptcy

Redwood Pharma
Regulatory press release26.06.2024, 11.00

Redwood Pharma provides a new update regarding divestment of company assets

Redwood Pharma
Press release12.06.2024, 12.00

Redwood Pharma provides an update on the process for divesting the company's assets

Redwood Pharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release23.05.2024, 13.00

Redwood Pharma provides an update on the company's future

Redwood Pharma
Press release08.05.2024, 08.30

Redwood Pharma's product RP501 attracted a lot of interest at ARVO in Seattle

Redwood Pharma
Press release07.05.2024, 08.30

Two international companies begin due diligence on Redwood Pharma's product RP501 ahead of potential commercial agreements

Redwood Pharma
Press release06.05.2024, 15.00

Redwood Pharma's board subscribes to units in the ongoing new issue

Redwood Pharma
Press release28.02.2024, 08.30

Redwood Pharma's innovative dry eye treatment to be presented at ARVO in Seattle

Redwood Pharma
Press release20.12.2023, 09.10

Redwood Pharma's CEO Martin Vidaeus in year-end interview

Redwood Pharma
Press release19.12.2023, 08.00

Redwood Pharma to participate in the JP Morgan Healthcare Conference

Redwood Pharma
Regulatory press release30.11.2023, 08.30

Redwood Pharma AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)

Redwood Pharma
Press release22.11.2023, 08.30

Redwood Pharma to participate in the NLS Days partner conference in Copenhagen

Redwood Pharma
Press release19.10.2023, 11.15

Redwood Pharma to participate in the BIO-Europe partnering conference in Munich

Redwood Pharma
Regulatory press release31.05.2023, 23.10

Redwood Pharma presents positive results from a clinical study with RP501 against dry eye

Redwood Pharma
Press release17.03.2023, 13.00

Redwood Pharma completes recruitment for clinical trial with RP501 for dry eye

Redwood Pharma
Press release24.01.2023, 08.30

Redwood Pharma takes important steps towards the commercial production of its dry eye product

Redwood Pharma
Regulatory press release15.12.2022, 17.00

Redwood Pharma enters partnership with Nextec medical in preparation for European market clearance of RP501

Redwood Pharma
Press release19.10.2022, 15.18

Interview with CEO Martin Vidaeus of Redwood Pharma at BioStock Investor Meeting, Stockholm

Redwood Pharma
Press release14.10.2022, 08.30

Redwood Pharma: Streamed video of CEO Martin Vidaeus presenting at Aktieportföljen Live in Stockholm, Sweden on Oct. 11, 2022

Redwood Pharma
Press release03.10.2022, 15.42

Redwood Pharma to present at AKTIEPORTFÖLJEN LIVE SVERIGE in Stockholm on 11[th] of Oct. 2022 at 14:45

Redwood Pharma